Related Experiment Video

Updated: Jul 17, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

DNA vaccines for cancer therapy

Horton1, Parker, Wloch

  • 1Vical, Inc., San Diego, CA 92121, USA. hhorton@vical.com

Expert Opinion on Investigational Drugs
|January 5, 2001
PubMed

Insights

Plasmid DNA (pDNA) cancer vaccines show promise in preclinical models, inducing immune responses and potentially preventing tumor growth. This novel immunotherapy offers advantages over other vaccine types for broad application in cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Cancer immunotherapy is an evolving field aiming to harness the immune system to fight malignancies.
  • Plasmid DNA (pDNA) vaccines represent a novel approach, delivering tumor antigens to stimulate anti-cancer immune responses.

Purpose of the Study:

  • To evaluate the efficacy of pDNA-based cancer vaccines in preclinical models.
  • To assess the immunogenicity and anti-tumor effects of pDNA vaccination.

Main Methods:

  • Vaccination of preclinical rodent tumor models with tumor antigen-expressing pDNA.
  • Assessment of humoral and cell-mediated immune responses.
  • Evaluation of tumor growth inhibition and protection against tumor development.

Main Results:

  • pDNA vaccination successfully elicited both humoral and cell-mediated immunity.
  • In some cases, pDNA vaccines demonstrated protection against tumor growth.
  • pDNA delivery of tumor antigens showed advantages in ease of manufacture, safety, and applicability compared to other vaccine platforms.

Conclusions:

  • pDNA cancer vaccines are a promising novel immunotherapy approach.
  • The identified tumor antigen genes and advances in genomics support the future clinical use of pDNA vaccines.
  • pDNA-based cancer vaccines hold potential for treating a wide range of human cancers.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...